Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study
The FAITH study enrolled a total of 158 hospitalised patients with moderate COVID-19 in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Umifenovir
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against…
In collaboration with Laxai Life Sciences, it aims to determine the safety and efficacy of three combination drugs…
Why drug repurposing needs first good science, then hope
The COVID-19 adversity has proved to be an opportunity to galvanise drug repurposing and development in India. But it is important…
Umifenovir gets DCGI nod for Phase III clinical trial against COVID-19
CSIR-CDRI has developed the process technology for Umifenovir and licensed the process technology for manufacturing and marketing…